Commonly used cancer drugs shown to boost MRSA antibiotics

Scientists at University of Galway have uncovered a link between commonly used anticancer drugs and antibiotics that could offer a new approach to tackling superbug infections. The research team set out to find new ways to treat methicillin-resistant Staphylococcus aureus (MRSA) infections using drugs that are currently ineffective because of antibiotic resistance—a growing challenge in health care. MRSA is a type of S. aureus bacteria that has developed resistance to commonly used antibiotics, making infections more difficult to treat.

Read it at Medical Xpress ↗

← Front page